Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)
Clinical trial NCT01431521 · COMPLETED
Trial details
- NCT number
- NCT01431521
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-26
- Primary completion
- 2012-09-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.